Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sacubitril/valsartan to valsartan on left ventricular remodeling in asymptomatic LV systolic dysfunction after myocardial infarction has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacubitril/Valsartan (sacubitril/valsartan)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2023-05-03